首页> 外文期刊>Journal of clinical laboratory analysis. >Evaluation and comparison of Abbott Jaffe and enzymatic creatinine methods: Could the old method meet the new requirements?
【24h】

Evaluation and comparison of Abbott Jaffe and enzymatic creatinine methods: Could the old method meet the new requirements?

机译:Abbott Jaffe和酶肌酸酐方法的评价与比较:旧方法是否符合新要求?

获取原文
获取原文并翻译 | 示例
           

摘要

Background The aim of this study is to evaluate and compare the analytical performance characteristics of the two creatinine methods based on the Jaffe and enzymatic methods. Methods Two original creatinine methods, Jaffe and enzymatic, were evaluated on Architect c16000 automated analyzer via limit of detection ( LOD ) and limit of quantitation ( LOQ ), linearity, intra‐assay and inter‐assay precision, and comparability in serum and urine samples. The method comparison and bias estimation using patient samples according to CLSI guideline were performed on 230 serum and 141 urine samples by analyzing on the same auto‐analyzer. Results The LOD s were determined as 0.1?mg/dL for both serum methods and as 0.25 and 0.07?mg/dL for the Jaffe and the enzymatic urine method respectively. The LOQ s were similar with 0.05?mg/dL value for both serum methods, and enzymatic urine method had a lower LOQ than Jaffe urine method, values at 0.5 and 2?mg/dL respectively. Both methods were linear up to 65?mg/dL for serum and 260?mg/dL for urine. The intra‐assay and inter‐assay precision data were under desirable levels in both methods. The higher correlations were determined between two methods in serum and urine ( r =.9994, r =.9998 respectively). On the other hand, Jaffe method gave the higher creatinine results than enzymatic method, especially at the low concentrations in both serum and urine. Conclusions Both Jaffe and enzymatic methods were found to meet the analytical performance requirements in routine use. However, enzymatic method was found to have better performance in low creatinine levels.
机译:背景技术本研究的目的是评估并比较基于贾维特和酶法的两种肌酐方法的分析性能特征。方法通过检测(LOD)极限(LOD)和定量限制(LOQ),线性,测定的限制,在架构C16000自动分析仪上评估两种原始肌酐方法,jaffe和酶,并在血清和尿液中的可比性下评估Architect C16000自动分析。通过在同一自动分析仪上分析,对使用根据CLSI指南的患者样品进行根据CLSI指南的方法比较和偏置估计。结果分别测定为血清方法的0.1μmg/ dl,分别为血清方法和0.25%和0.07μmg/ dl。 LOQ S与血清方法的0.05〜Mg / DL值类似,酶尿液方法比jaffe尿法,分别为0.5和2×mg / dl的值。两种方法为血清的65〜20μg/ dL的线性和尿液中的260毫克/ dL。测定内和测定间精度数据两种方法都是所需的水平。在血清和尿液中的两种方法之间测定较高的相关性(分别为r = .994,r = .9998)。另一方面,贾维特方法比酶法产生更高的肌酐,尤其是血清和尿液中的低浓度。结论发现jaffe和酶法均符合常规用途的分析性能要求。然而,发现酶促方法在低肌酐水平中具有更好的性能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号